Tuesday, March 06, 2018 10:15 PM ET
Radius Health (RDUS) Insider Makes Significant Share purchase Extending the Buying Trend over Last Quarter
There was a noteworthy insider buy in Radius Health shares today as revealed in a filing with the SEC. One insider — Biotech Growth N V, 10% Owner — acquired 160,000 shares in the company having a net market value of approximately $5,202,896. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 75,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 235,000 shares and have averaged 117,500 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Radius Health is greater than its 285-company peer group average. The Bio Therapeutic Drugs peer group saw 319 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Radius Health insiders is lower than its peers. Within the peer group there were 27,096,829 shares purchased and 13,769,904 shares sold with company insiders purchasing 66,303 shares on average over this time period.
The data used in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.